Deep learning in virtual screening: recent applications and developments

TB Kimber, Y Chen, A Volkamer - International journal of molecular …, 2021 - mdpi.com
Drug discovery is a cost and time-intensive process that is often assisted by computational
methods, such as virtual screening, to speed up and guide the design of new compounds …

Mol2vec: unsupervised machine learning approach with chemical intuition

S Jaeger, S Fulle, S Turk - Journal of chemical information and …, 2018 - ACS Publications
Inspired by natural language processing techniques, we here introduce Mol2vec, which is
an unsupervised machine learning approach to learn vector representations of molecular …

KLIFS: an overhaul after the first 5 years of supporting kinase research

GK Kanev, C de Graaf, BA Westerman… - Nucleic acids …, 2021 - academic.oup.com
Kinases are a prime target of drug development efforts with> 60 drug approvals in the past
two decades. Due to the research into this protein family, a wealth of data has been …

[HTML][HTML] Proteochemometrics–recent developments in bioactivity and selectivity modeling

BJ Bongers, AP IJzerman, GJP Van Westen - Drug Discovery Today …, 2019 - Elsevier
Proteochemometrics is a machine learning based modeling approach relying on a
combination of ligand and protein descriptors. With ongoing developments in machine …

Sequence-based prediction of protein binding regions and drug–target interactions

I Lee, H Nam - Journal of cheminformatics, 2022 - Springer
Identifying drug–target interactions (DTIs) is important for drug discovery. However,
searching all drug–target spaces poses a major bottleneck. Therefore, recently many deep …

Learning with multiple pairwise kernels for drug bioactivity prediction

A Cichonska, T Pahikkala, S Szedmak… - …, 2018 - academic.oup.com
Motivation Many inference problems in bioinformatics, including drug bioactivity prediction,
can be formulated as pairwise learning problems, in which one is interested in making …

Drug discovery maps, a machine learning model that visualizes and predicts kinome–inhibitor interaction landscapes

APA Janssen, SH Grimm, RHM Wijdeven… - Journal of Chemical …, 2018 - ACS Publications
The interpretation of high-dimensional structure–activity data sets in drug discovery to
predict ligand–protein interaction landscapes is a challenging task. Here we present Drug …

Evaluating polymer representations via quantifying structure–property relationships

R Ma, Z Liu, Q Zhang, Z Liu, T Luo - Journal of chemical …, 2019 - ACS Publications
Machine learning techniques are being applied in quantifying structure–property
relationships for a wide variety of materials, where the properly represented materials play …

[HTML][HTML] CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling

L Pu, M Singha, J Ramanujam, M Brylinski - Oncotarget, 2022 - ncbi.nlm.nih.gov
Abstract Development of novel anti-cancer treatments requires not only a comprehensive
knowledge of cancer processes and drug mechanisms of action, but also the ability to …

MIDF-DMAP: Multimodal information dynamic fusion for drug molecule activity prediction

W Yi, L Zhang, Y Xu, X Cheng, T Chen - Expert Systems with Applications, 2025 - Elsevier
Background Computer-aided drug development can alleviate limitations in drug research
and development processes, such as long cycles, high costs, and limited targeting. Deep …